Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
2.6%
1w
5.9%
1m
5.0%
3m
7.3%
6m
2.1%
1y
57.5%
all
31.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 618 2.6%
580
721
Company Overview

Sales
1,968 Cr
Growth: 6.0%
Profit after Tax
228 Cr
Growth: 1.3%
Small Cap
5,599 Cr
P/E: 24.6x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 1,968
Growth 6.0%
EBITDA 20.5%
P/S 2.8x
Dividend 0.4%
P/E 24.6x
Book Value ₹ 206
PEG Ratio 4.1x
ROE 12.8%
P/B 3.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (8)